2025
SJR Q1
JCR Q1 · 8,7
4 matched articles
SCIE
Journal detail
Reviews in Endocrine and Metabolic Disorders
- Publisher
- Springer
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1389915515732606
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 2,834
- Quartile Q1
- H-Index 113
- Cites/doc 10,23
- Docs (3y) 242
- Cites (3y) 2.665
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 8,7
- 5Y JIF 9,7
- JCI 1,55
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Endocrinology Q1
- Endocrinology, Diabetes and Metabolism Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS categories
- Endocrinology & Metabolism
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 2,834 | 8,7 | 9,7 | 1,55 | Q1 | 113 |
| 2024 | Q1 | Q1 | 2,446 | 8 | 9 | 1,74 | Q1 | 106 |
| 2023 | Q1 | Q1 | 2,075 | 6,9 | 8,4 | 1,53 | Q1 | 106 |
| 2022 | Q1 | Q1 | 1,835 | 8,2 | 9,3 | 1,61 | Q1 | 106 |
| 2021 | Q1 | Q1 | 1,78 | 9,3 | 9,1 | 1,32 | Q1 | 106 |
| 2020 | Q1 | Q1 | 1,916 | 6,5 | 8,3 | 1,08 | Q1 | 106 |
| 2019 | Q1 | Q1 | 1,641 | 6,2 | 6,5 | 1 | Q2 | 106 |
| 2018 | — | Q1 | — | 5,5 | 6,4 | 1,13 | Q1 | — |
| 2017 | Q1 | Q1 | 2,089 | 5 | 5,5 | 1,03 | Q1 | 106 |
| 2016 | Q1 | Q1 | 2,309 | 4,8 | 4,7 | — | — | 106 |
| 2015 | Q1 | Q1 | 2,353 | 5,1 | 4,8 | — | — | 106 |
| 2014 | Q1 | Q1 | 1,86 | 4,9 | 4,4 | — | — | 106 |
| 2013 | Q1 | Q2 | 1,841 | 3,8 | 4 | — | — | 106 |
| 2012 | Q1 | Q1 | 1,547 | 4,6 | 4,5 | — | — | 106 |
| 2011 | Q1 | Q2 | 1,599 | 3,2 | 4,5 | — | — | 106 |
| 2010 | Q1 | Q2 | 1,512 | 4,1 | 4,5 | — | — | 106 |
| 2009 | — | Q1 | — | 5,4 | 4,3 | — | — | — |
| 2008 | — | Q1 | — | 4,7 | 3,2 | — | — | — |
| 2007 | — | Q3 | — | 1,9 | — | — | — | — |
| 2006 | — | Q3 | — | 1,9 | — | — | — | — |
| 2005 | — | Q3 | — | 2,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 14/198 |
| 2024 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 15/193 |
| 2023 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 17/186 |
| 2022 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 13/145 |
| 2021 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 12/146 |
| 2020 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 23/146 |
| 2019 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q2 | 15/143 |
| 2018 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 23/145 |
| 2017 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | Q1 | 25/142 |
| 2016 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 23/138 |
| 2015 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 20/133 |
| 2014 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 21/128 |
| 2013 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 38/124 |
| 2012 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 26/122 |
| 2011 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 49/122 |
| 2010 | ENDOCRINOLOGY & METABOLISM | SCIE | Q2 | — | 34/116 |
| 2009 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 15/105 |
| 2008 | ENDOCRINOLOGY & METABOLISM | SCIE | Q1 | — | 21/93 |
| 2007 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 64/92 |
| 2006 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 62/93 |
| 2005 | ENDOCRINOLOGY & METABOLISM | SCIE | Q3 | — | 50/89 |